Chapter 3: Market Overview
- Introduction to Clinical Nutrition
- Clinical Nutrition Product Ingredients
- Nutritional Interventions
- Market Dynamics
- Drivers
- Restraints
- Regulatory Landscape
- Regulations on Infant Formula
Chapter 4: Impact of COVID-19
- Overview
- COVID-19 Crisis
- Impact of COVID-19 on the Market for Clinical Nutrition
- Clinical Nutrition Practice During the COVID-19 Pandemic
- Current Outlook
Chapter 5: Medical Nutrition Background
- Oral Nutrition Supplementation
- Indications for ONS prescribing
- Dietary Supplements
- Functional/Fortified Food and Beverages
- Food Intolerance Products
Chapter 6: Market Breakdown by Type of Clinical Nutrition
- Enteral Nutrition
- Oral Feeding
- Tube Feeding
- Enteral Feed Administration
- Enteral Feeding Pump
- Enteral Formula
- Blenderized Diet
- Standard/Polymeric Nutrition
- Elemental and Semi-Elemental Nutrition
- Disease-Specific
- Market Size and Forecast
- Parenteral Nutrition
- Constituents of Total Parental Nutrition
- Carbohydrates
- Lipids
- Trace Elements
- Amino Acids (AA)
- Vitamins and Minerals
- Important Minerals in PN
- Market Size and Forecast
- Infant Nutrition
- Milk-Based Formula
- Organic Formula
- Hydrolyzed and Soy-Based Formula
- Probiotics and Prebiotics
- Follow-on Formula
- Others
- Market Size and Forecast
Chapter 7: Market Breakdown by End User
- End-User Market Size
- Infants and Children
- Infants
- Children
- Adults
- Elders
Chapter 8: Market Breakdown by Clinical Nutrition Application
- Therapeutic Area
- Oncology
- Gastroenterology
- Nephrology
- Neurology
- Diabetes
- Immunology
- Critical Care
- Healthcare Settings
- Acute Care Hospitals
- Nursing Homes
- Home Care Settings
- Inpatient Rehabilitation Facilities
Chapter 9: Market Breakdown by Region
- Overview
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain and Portugal
- Scandinavia
- Benelux
- Asia-Pacific
- China
- India
- Japan
- Australia and New Zealand
- South Korea
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
Chapter 10: Patent Review
Chapter 11: Competitive Landscape
- Major Players and Market Share
- Mergers and Acquisitions
- New Product Launches
- Agreements, Collaborations and Partnerships
Chapter 12: Analysis of Market Opportunities
- Porter's Analysis
- Threat of New Entrants
- Threat of Substitute Products or Services
- Bargaining Power of Customers (Buyers)
- Bargaining Power of Suppliers
- Intensity of Competitive Rivalry
- PEST (Political, Economic, Social, Technology) Analysis
- Political
- Economic
- Social
- Technology
Chapter 13: Company Profiles
- Abbott
- Baxter International Inc.
- B Braun Melsungen AG
- Danone
- DSM
- DuPont
- Fresenius Kabi AG
- Glanbia plc
- Lonza
- Mead Johnson & Co. LLC (Reckitt Benckiser Group plc)
- Nestlé
- Otsuka Holdings Co. Ltd.
- Perrigo Co. plc
List of Tables
Summary Table: Global Market for Clinical Nutrition, by Region, Through 2025
Table 1: Examples Clinical Nutrition Ingredients
Table 2: Trends in Global Elderly (60+ Years) Population Growth, 1980-2020
Table 3: Treatment Cost of Chronic Diseases in the U.S., 2016
Table 4: Global Diabetes Estimates and Projections, 2019-2045
Table 5: Selected Medical Food Manufacturers and End Users
Table 6: Distribution of Healthcare Spending in the U.S., by Sponsors, 2019
Table 7: Annual Healthcare Expenditures in Selected Countries, 2019
Table 8: Abbott's Oral Nutritional Supplements
Table 9: Distribution of Most Popular Dietary Supplements, 2016
Table 10: Selected Nutritional Supplements
Table 11: Recommended Nutrient Intake
Table 12: Enteral Feeding Devices
Table 13: Enteral Feeding Administration Methods
Table 14: Enteral Formula
Table 15: Global Market for Enteral Nutrition, by Type, Through 2025
Table 16: Global Market for Enteral Nutrition, by Region, Through 2025
Table 17: Basic Adult Daily Requirements for Total Parenteral Nutrition
Table 18: Constituents of TPN for Children
Table 19: Currently Approved ILEs, U.S.
Table 20: Multi-Trace Element (MTE) Formulations Currently Available, U.S.
Table 21: Selected Commercially Used Amino Acid Formulations
Table 22: Selected Amino Acid Formulation Details
Table 23: Global Market for Parenteral Nutrition, by Type, Through 2025
Table 24: Global Market for Parenteral Nutrition, by Region, Through 2025
Table 25: Global Market for Infant Nutrition, by Region, Through 2025
Table 26: Global Market for Infant Nutrition, by Type, Through 2025
Table 27: Global Market for Clinical Nutrition, by End User, Through 2025
Table 28: Preterm Births in the U.S., 2016
Table 29: Recommended Enteral Nutrient Intake for Preterm Infants
Table 30: Types of Enteral Clinical Nutrition for Children
Table 31: Examples of Total Parenteral Solutions for Adults
Table 32: Daily Nutritional Requirements for CKD
Table 33: Nutritional Therapy for Neurological Disorders
Table 34: Nutritional Recommendations for People with Diabetes
Table 35: U.S. Hospitals, by Type, 2016
Table 36: Certified Nursing Facilities in the U.S., by U.S. State, 2019
Table 37: Distribution of Malnutrition and Other Diet-Related Health Conditions in North America, by Country, 2016
Table 38: North American Market for Clinical Nutrition, by Country, Through 2025
Table 39: European Prevalence of Malnutrition and Other Diet-Related Health Conditions, 2016
Table 40: European Market for Clinical Nutrition, by Country, Through 2025
Table 41: Asia-Pacific Prevalence of Malnutrition and Other Diet-Related Health Conditions, 2016
Table 42: Asia-Pacific Market for Clinical Nutrition, by Country, Through 2025
Table 43: Middle East and African Market for Clinical Nutrition, by Country, Through 2025
Table 44: Middle East and African Prevalence of Malnutrition and Other Diet-Related Health Conditions, 2019
Table 45: African Prevalence of Malnutrition, Children Under Five, 2016
Table 46: South American Prevalence of Malnutrition and Other Diet-Related Health Conditions, 2016
Table 47: South American Market for Clinical Nutrition, by Country, Through 2025
Table 48: Key Strategies and Public Policies, Food and Nutrition Security, Brazil, 2015
Table 49: U.S. Patents on Clinical Nutrition Products, 2020
Table 50: U.S. Patents on Clinical Nutrition Products, 2019
Table 51: U.S. Patents on Clinical Nutrition Products, 2018
Table 52: U.S. Patents on Clinical Nutrition Products, 2017
Table 53: U.S. Patents on Clinical Nutrition Products, 2016
Table 54: Abbott: Nutritional Products and R &D Investment, 2018-2020
Table 55: Mergers and Acquisitions in the Clinical Nutrition Industry, 2016-2021
Table 56: New Product Launches in the Clinical Nutrition Industry, 2016-2021
Table 57: Agreements, Collaborations and Partnerships in the Clinical Nutrition Industry, 2016-2021
Table 58: Abbott Nutrition: Nutritional Products
Table 59: Abbott: Business Highlights, 2020
Table 60: Baxter International Inc.: Nutritional Care
Table 61: Baxter International Inc.: Key Developments, 2020
Table 62: B. Braun Melsungen AG: Nutritional Therapy Products
Table 63: B. Braun Melsungen AG: Nutrition Therapy Delivery Devices
Table 64: B. Braun Melsungen AG: Key Developments, 2019
Table 65: Danone: Specialized Nutrition Products
Table 66: Danone: Key Developments, 2020
Table 67: DSM: Nutritional Products
Table 68: DuPont: Nutritional Products
Table 69: Fresenius Kabi: Clinical Nutrition Products
Table 70: Fresenius Kabi: Key Developments, 2019
Table 71: Glanbia plc: Nutritional Products
Table 72: Glanbia plc: Key Developments, 2020
Table 73: Lonza: Human Nutrition Products
Table 74: Lonza: Key Developments, 2019
Table 75: Mead Johnson: Nutrition Products
Table 76: Nestlé: Nutrition Products
Table 77: Nestlé: Key Developments, 2017
Table 78: Otsuka Pharmaceuticals: Nutrition Products
Table 79: Otsuka: Key Developments, 2020
Table 80: Perrigo Co., plc: Nutritional Products
Table 81: Perrigo Co., plc: Key Developments, 2020
Table 82: Acronyms Used in This Report
List of Figures
Summary Figure A: Global Market for Clinical Nutrition, 2019-2025
Summary Figure B: Global Market for Clinical Nutrition, by Type, 2019-2025
Figure 1: Prevalence of Moderate to Severe Food Insecurity, by Region, 2016
Figure 2: Trends in Global Elderly (60+ Years) Population Growth, 1990-2100
Figure 3: Shares of Population Aged 65+ in G7 Countries, 2016
Figure 4: Distribution of Total Medicare Home Healthcare Spending, 2019
Figure 5: Medical Nutrition Support Pathway
Figure 6: ONS Supplementation Process Flow Chart
Figure 7: Distribution of Top Dietary Supplement Indications, 2016
Figure 8: Global Market for Enteral Nutrition, 2019-2025
Figure 9: Global Market Shares of Enteral Nutrition, by Key Players, 2019
Figure 10: Global Market for Parenteral Nutrition, 2019-2025
Figure 11: Global Market for Infant Nutrition, 2019-2025
Figure 12: Global Aging Population, 1990-2100
Figure 13: Distribution Share of U.S. Hospitals, by Type, 2016
Figure 14: Global Market for Clinical Nutrition, by Region, 2019-2025
Figure 15: North American Market for Clinical Nutrition, 2019-2025
Figure 16: Mexican Prevalence of Stunting in Children Under Five, 1996-2015
Figure 17: Mexican Mortality Rate in Children Under Five, 2011-2015
Figure 18: European Market for Clinical Nutrition, 2019-2025
Figure 19: German Prevalence of Adult Overweight and Obesity, 2014
Figure 20: Undernourishment in Asia-Pacific, 2005-2016
Figure 21: Asia-Pacific Market for Clinical Nutrition, 2020-2025
Figure 22: Middle East and African Market for Clinical Nutrition, 2019-2025
Figure 23: Saudi Arabian Mortality Rate, Children Under Five, 2011-2015
Figure 24: South American Market for Clinical Nutrition, 2019-2025
Figure 25: Changes in Brazil's Nutrition Status from 1980-2015
Figure 26: Global Market Shares of Clinical Nutrition, by Key Players, 2019
Figure 27: Porter's Analysis: Threat of New Entrants to the Industry
Figure 28: Porter's Analysis: Threat of Clinical Nutrition Substitute Products
Figure 29: Porter's Analysis: Bargaining Power of Buyers, Clinical Nutrition Industry
Figure 30: Porter's Analysis: Bargaining Power of Suppliers in the Clinical Nutrition Industry
Figure 31: Porter's Analysis: Intensity of Competition Among Players in the Clinical Nutrition Industry
Figure 32: Abbott: Annual Revenue, 2018-2020
Figure 33: Abbott: Revenue Share, by Segment, 2019
Figure 34: Abbott Nutrition: Revenue Share, by Segment, 2019
Figure 35: Baxter International Inc.: Annual Revenue, 2018-2020
Figure 36: Baxter International Inc.: Revenue Share, by Segment, 2019
Figure 37: Baxter International Inc.: Clinical Nutrition Revenues, 2018-2020
Figure 38: B. Braun Melsungen AG: Annual Revenue, 2018-2020
Figure 39: B. Braun Melsungen AG: Revenue Share, by Division, 2019
Figure 40: Danone: Annual Revenue, 2018 and 2019
Figure 41: Danone: Revenue Share, by Segment, 2019
Figure 42: DSM: Annual Revenue, 2018-2020
Figure 43: DSM: Revenue Share, by Segment, 2019
Figure 44: DSM: Revenue, by Nutrition Segment, 2018-2020
Figure 45: DuPont: Annual Revenue, 2018-2020
Figure 46: DuPont: Revenue Share, by Geography, 2019
Figure 47: Fresenius Kabi: Annual Revenue, 2018-2020
Figure 48: Fresenius Kabi: Revenue Share, by Segment, 2019
Figure 49: Fresenius Kabi: Clinical Nutrition Revenue, 2018-2020
Figure 50: Glanbia plc: Annual Revenue, 2018-2020
Figure 51: Glanbia plc: Revenue Share, by Segment, 2019
Figure 52: Lonza: Annual Revenue, 2018-2020
Figure 53: Lonza: Revenue Share, by Segment, 2019
Figure 54: Mead Johnson Nutrition: Annual Revenue, 2018 and 2019
Figure 55: Mead Johnson Nutrition: Revenue Share, by Segment, 2019
Figure 56: Nestlé: Annual Revenue, 2018 and 2019
Figure 57: Nestlé: Revenue Share, by Segment, 2019
Figure 58: Otsuka: Annual Revenue, 2018-2020
Figure 59: Otsuka: Revenue, by Segment, 2019
Figure 60: Otsuka Pharmaceuticals: Clinical Nutrition Revenue, 2019
Figure 61: Perrigo Co., plc: Annual Revenue, 2018-2020
Figure 62: Perrigo Co., plc: Revenue Share, by Segment, 2019
